March 24, 2025 · STOCK Act disclosure
Representative George Whitesides (Democrat-CA) sold Theravance Biopharma, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on March 24, 2025 and was disclosed on April 23, 2025 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.